SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-026549
Filing Date
2021-05-11
Accepted
2021-05-11 16:11:46
Documents
18
Period of Report
2021-05-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sndx-8k_20210511.htm   iXBRL 8-K 33402
2 EX-99.1 sndx-ex991_6.htm EX-99.1 154830
3 GRAPHIC g3eaaw2vs1la000001.jpg GRAPHIC 34522
4 GRAPHIC g3eaaw2vs1la000005.jpg GRAPHIC 34522
5 GRAPHIC g3eaaw2vs1la000004.jpg GRAPHIC 34522
6 GRAPHIC g3eaaw2vs1la000002.jpg GRAPHIC 34522
7 GRAPHIC g3eaaw2vs1la000003.jpg GRAPHIC 34522
  Complete submission text file 0001564590-21-026549.txt   575191

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA sndx-20210511.xsd EX-101.SCH 5768
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20210511_lab.xml EX-101.LAB 20985
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20210511_pre.xml EX-101.PRE 12539
11 EXTRACTED XBRL INSTANCE DOCUMENT sndx-8k_20210511_htm.xml XML 3794
Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37708 | Film No.: 21911399
SIC: 2834 Pharmaceutical Preparations